• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 119.00(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 577.0
  • ISIN : INE351A01035
589.80 -12 (-1.97%)
  • As on 17 Jun 2025 (EOD)
  • Today’s Low

    587.00
  • Today’s High

    607.55
  • Open

    606.00
  • Perv Close

    601.65
  • 52W Low

    510.20
  • 52W High

    937.95

Key Indicators

  • P/E(TTM)

    26.04

  • Mar.Cap (₹Cr.)

    4,152.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    349.37

  • Debt-Equity Ratio

    -1.97

  • AGM Date

    17-Jun-2025

  • EPS

    22.64

  • P/E Ratio

    26.04

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    4,152.53

  • RONW (%)

    -1.17

  • ROCE (%)

    0.39

Score Board

  • Equity (₹ in Cr.)

    14.08

  • BV (₹)

    349.40

  • Sales( ₹ in Cr.)

    1,735.70

  • NP (in Cr.)

    159.39

  • NP Var(%)

    540.0

  • Div%

    0.0

  • CPS (₹)

    38.00

  • EPS (₹)

    22.60

  • Traded Value (₹ in Lakhs)

    4,229.98

  • 52 Week High

    937.95

  • 52 Week Low

    510.20

  • Price BSE

    601.0

  • Price NSE

    602.00

  • Market Capital( in Cr.)

    4,229.98

  • P/C Ratio

    15.80

  • P/E Ratio

    26.50

  • Price Vs.BV

    22.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,442.17 1,072.43 942.93 1,123.97 904.44 967.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,442.17 1,072.43 942.93 1,123.97 904.44 967.74
Other Income 98.40 41.85 42.07 47.37 99.17 103.30
Stock Adjustments 26.36 -22.01 52.79 16.73 18.50 30.54
Total Income 1,566.93 1,092.27 1,037.79 1,188.07 1,022.11 1,101.58
EXPENDITURE :            
Raw Materials 717.83 501.86 436.27 449.67 401.25 443.38
Power and Fuel Cost 105.64 101.41 77.12 67.95 72.14 75.43
Employee Cost 283.14 270.86 250.79 234.04 205.16 176.76
Other Manufacturing Expenses 74.62 70.61 73.49 64.48 68.09 62.57
Selling and Administration Expenses 236.37 194.89 192.65 225.80 263.43 281.65
Miscellaneous Expenses 125.62 116.36 8.95 3.28 3.48 19.29
Employee Benefit Expenses 283.14 270.86 250.79 234.04 205.16 176.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,543.23 1,256.00 1,039.27 1,045.23 1,013.55 1,059.07
Operating Profit 23.70 -163.73 -1.49 142.84 8.56 42.51
Interest 10.42 9.38 2.07 1.30 1.28 0.62
Gross Profit 13.28 -173.11 -3.56 141.54 7.28 41.89
Depreciation 105.46 105.98 83.19 75.89 71.09 61.71
Profit Before Tax -92.18 -279.09 -86.75 65.65 -63.81 -19.82
Current Tax 0.00 0.00 0.00 0.00 0.00 -1.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 20.61 -31.32 11.56 -7.50 -27.38
Reported Net Profit -92.18 -299.70 -55.43 54.08 -56.32 8.80
Extraordinary Items -55.94 -103.16 -0.25 0.02 -1.45 -9.09
Adjusted Net Profit -36.24 -196.54 -55.18 54.06 -54.87 17.89
Adjustment below Net Profit 0.00 121.81 0.00 0.00 0.00 -7.23
P & L Balance brought forward 2,359.31 2,565.36 2,648.96 2,623.04 2,712.21 2,745.81
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -12.05 28.16 28.16 28.16 32.85 35.17
P & L Balance carried down 2,279.18 2,359.31 2,565.36 2,648.96 2,623.04 2,712.21
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 200.00 200.00 200.00 200.00 200.00
Dividend Per Share(Rs) 0.00 4.00 4.00 4.00 4.00 4.00
Earnings Per Share-Unit Curr -13.09 -42.57 -7.87 7.68 -8.00 1.25
Earnings Per Share(Adj)-Unit Curr -13.09 -42.57 -7.87 7.68 -8.00 1.25
Book Value 325.91 338.65 379.52 383.11 375.99 388.15
Book Value(Adj)-Unit Curr 325.91 338.65 379.52 383.11 375.99 388.15

Shareholding Pattern

  • Promoter Group

    70.22%

  • Public Share Holding

    29.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 37,081,011 52.67 37,081,011 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,221,224 17.36 12,221,224 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 138,351 0.20 138,351 3
Others 0 0.00 0 0
Sub Total 49,440,586 70.22 49,440,586 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,954 0.03 22,454 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 691,030 0.98 690,530 39
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 500 0.00 500 1
Insurance Companies 153,628 0.22 153,628 2
Mutual Funds / UTI 6,960,245 9.89 6,960,245 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 833,321 1.18 833,321 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,661,678 12.30 8,660,678 55
2] Non Institution
Bodies Corporate 253,912 0.36 253,832 132
Clearing Members 30 0.00 30 2
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 422,673 0.60 420,673 473
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 361,495 0.51 361,495 633
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,238,582 1.76 570,457 5
Individuals holding nominal share capital up to Rs. 1 lakh 9,184,245 13.04 8,389,258 20,301
Market Maker 2 0.00 2 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 744,892 1.06 744,892 1
Sub Total 12,303,486 17.48 10,838,294 21,558
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 70,405,750 100.00 68,939,558 21,621

Company Background

Unichem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Unichem Laboratories Ltd
  • BSE Code : 577.0
  • ISIN : INE351A01035
  • Incorporation Year

    1962

  • Registered Office

    Unichem Bhavan Prabhat Estate
    Off S V Road Jogeshwari (West), Mumbai,
    Maharashtra-400102

  • Telephone

    91-22-66888333

  • FAX

    91-22-26784391

  • Chairman

    Prakash A Mody

  • Managing Director

    Pabitra Bhattacharya

  • Company Secretary

    Pradeep Bhandari

  • Auditor

    N A Shah Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Unichem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unichem Labs. 589.65 1,472.55 1,442.17 25.47 -1.05
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92